Abstract
Cholecystokinin (CCK) is a hormone that has important physiological effects on energy balance. This study has utilized a stable CCK1 receptor agonist, (pGlu-Gln)-CCK-8, to evaluate the metabolic effects of prolonged administration in normal mice. Twice daily injection of (pGlu-Gln)-CCK-8 for 28 days resulted in significantly lowered body weights (P
Original language | English |
---|---|
Pages (from-to) | 53-59 |
Journal | Journal of Endrocrinology |
Volume | 216 |
Issue number | 1 |
DOIs | |
Publication status | Published (in print/issue) - 2 Jan 2013 |